Vicki L. Keedy

Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Margaret von Mehren, John M. Kane, Mark Agulnik et al. · Journal of the National Comprehensive Cancer Network · 2022 · 1.1K citations · Full text

Surgical Oncology, Tumoral Pathology, Soft Tissue Sarcoma +15

Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

Margaret von Mehren, R. Lor Randall, Robert S. Benjamin et al. · Journal of the National Comprehensive Cancer Network · 2018 · 720 citations · Full text

Surgical Oncology, Cancer Management, Pathology +16

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

William D. Tap, Zev A. Wainberg, Stephen P. Anthony et al. · New England Journal of Medicine · 2015 · 571 citations

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (<i>EGFR</i>) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

Vicki L. Keedy, Sarah Temin, Mark R. Somerfield et al. · Journal of Clinical Oncology · 2011 · 479 citations

First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study

Ryan J. Sullivan, Jeffrey R. Infante, Filip Jankú et al. · Cancer Discovery · 2017 · 401 citations